Since 2006 people with Multiple Sclerosis (MS), Neuromyelitis Optica (NMO), and MOG antibody disease (MOGAD) living in the Hunter New England region have been supported by the John Hunter Hospital MS service: an outpatient clinic based on a model of self-management, regular and routine MS specialist review, emergency department and inpatient avoidance and early access to therapy to improve life quality and minimise disability accrual.
Neurological care is provided in an outpatient-based model of care, aligned with the globally recognised standard of care, MS Brain Health. The key aspects of the MS care pathway are early referral and diagnosis, timely treatment commencement, timely review of new symptoms and routine, ongoing review.
The purpose of this page is to support people living with neuroimmunological disease (MS, MOGAD and NMOSD), with information and tools to promote self management. It is also to link the medical community with people with MS (PwMS), to improve communication and facilitate a person-focused service. Finally, it is an opportunity to link those with an interest to work or study in this field with infrastructure and the expertise and support of both the PwMS and the MS team.
ARTiMS Survey
The first step in participating in our ARTiMS study is to fill out this survey - Pregnancy survey
World MS Day 2024 - John Hunter Hospital Seminars are now available for viewing!
Afternoon session - World MS Day Seminar Part 1.
Night session - World MS Day Seminar Part 2.
Nurse Pearls
If in doubt, call us! Not sure if your new symptom is something to worry about? Call us. Want to discuss family planning and MS? Call us. It's better to call for advice. If you don't want to call, you can also email us instead.
- Telephone: 02 4921 3540
- Fax: 02 49236571
- Email: hnelhd-msclinic@health.nsw.gov.au
ECTRIMS Patient Community Day
Date: Friday, 20 September 2024 |15:00 - 18:00 CEST | 23:00 - 02:00 AEST
Location: Bella Center Copenhagen, Denmark, and Online
Languages: Live in English, with AI-powered translations in 50+ languages
Please note that NBN accidentally mixed up the captions between Professor Jeannette Lechner-Scott (Head of the MS Clinic) and Jessie Scott (Patient Advocacy Group).
What's New?
Our ANZAN 2023 presentation
How our understanding about multiple sclerosis has changed over the last 30 years presented by Jeannette Lechner-Scott at ANZAN 2023 - credit to ANZAN for the video https://www.anzan.org.au/
Information on MOG Antibody disease
MOG Antibody disease is a rare demyelinating disease that follows a similar pattern of inflammation to that of MS.
This webpage is regularly monitored and updated by the MS Clinic staff. If you have a comment please let us know here.